Back
Cidara Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
83
CDTX
Cidara Therapeutics
Last Price:
20.00
Seasonality Move:
10.99%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight buying pressure.
Cidara Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.03 | Buy |
| 20-day SMA: | 14.83 | Buy |
| 50-day SMA: | 12.59 | Buy |
| 200-day SMA: | 13.1 | Buy |
| 8-day EMA: | 17.48 | Buy |
| 20-day EMA: | 15.42 | Buy |
| 50-day EMA: | 13.6 | Buy |
| 200-day EMA: | 13.48 | Buy |
Cidara Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.77 | Buy |
| Relative Strength Index (14 RSI): | 75.13 | Buy |
| Chaikin Money Flow: | 16003 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.97 - 16.63) | Buy |
| Bollinger Bands (100): | (10.63 - 14.15) | Buy |
Cidara Therapeutics Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cidara Therapeutics Stock
Is Cidara Therapeutics Stock a Buy?
- Cidara Therapeutics share price is 19.59 while CDTX 8-day simple moving average is 17.03, which is a Buy signal.
- The stock price of CDTX is 19.59 while Cidara Therapeutics 20-day SMA is 14.83, which makes it a Buy.
- Cidara Therapeutics 50-day simple moving average is 12.59 while CDTX share price is 19.59, making it a Buy technically.
- CDTX stock price is 19.59 and Cidara Therapeutics 200-day simple moving average is 13.10, creating a Buy signal.
CDTX Technical Analysis vs Fundamental Analysis
Buy
83
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy or a Sell?
-
Cidara Therapeutics stock is rated a Buy
The current Cidara Therapeutics [CDTX] share price is $19.59. The Score for CDTX is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
Cidara Therapeutics Stock Info
Market Cap:
138.04M
Price in USD:
19.59
Share Volume:
32.83K
Cidara Therapeutics 52-Week Range
52-Week High:
24.40
52-Week Low:
10.00
Buy
83
Cidara Therapeutics (CDTX)
is a Buy
Cidara Therapeutics Share Price Forecast
-
What is the Cidara Therapeutics stock price today?
The Cidara Therapeutics stock price is 19.59 USD today. -
Will CDTX stock go up or go down?
Cidara Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Cidara Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cidara Therapeutics is not overvalued.
Is Cidara Therapeutics Stock a Buy?
- Cidara Therapeutics share price is 19.59 while CDTX 8-day exponential moving average is 17.48, which is a Buy signal.
- The stock price of CDTX is 19.59 while Cidara Therapeutics 20-day EMA is 15.42, which makes it a Buy.
- Cidara Therapeutics 50-day exponential moving average is 13.60 while CDTX share price is 19.59, making it a Buy technically.
- CDTX stock price is 19.59 and Cidara Therapeutics 200-day simple moving average is 13.48, creating a Buy signal.
Fundamental Analysis of Cidara Therapeutics
Is Cidara Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $1.97 per share, a decrease next quarter of $0.00 per share, a decrease this year of $18.96 per share, and an increase next year of $15.14 per share.
Technical Analysis of Cidara Therapeutics
Should I short Cidara Therapeutics stock?
- CDTX Moving Average Covergence Divergence (MACD) indicator is 1.77, suggesting Cidara Therapeutics is a Buy
- Cidara Therapeutics Relative Strength Index (RSI) is 75.13, which suggest Cidara Therapeutics is overbought
- The Bollinger Bands (25) for Cidara Therapeutics is (11.97 - 16.63), which suggest Cidara Therapeutics is a Buy
- The Bollinger Bands (100) for Cidara Therapeutics is (10.63 - 14.15), which suggest Cidara Therapeutics is a Buy
* Cidara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.